Cleared Abbreviated

KION ANAESTHESIA SYSTEM, MODEL 65 03 879 E392E (K010923) - FDA 510(k) Clearance

Class II Cardiovascular device cleared through the Abbreviated 510(k) pathway - typically does not require clinical trials.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jan 2002
Decision
302d
Days
Class 2
Risk

K010923 is an FDA 510(k) clearance for the KION ANAESTHESIA SYSTEM, MODEL 65 03 879 E392E. Classified as Monitor, Physiological, Patient(with Arrhythmia Detection Or Alarms) (product code MHX), Class II - Special Controls.

Submitted by Siemens Elema AB (Iselin, US). The FDA issued a Cleared decision on January 23, 2002 after a review of 302 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1025 - the FDA cardiovascular device oversight framework. The Abbreviated 510(k) pathway was used, relying on FDA-recognized standards to demonstrate substantial equivalence.

Device pattern: Standards-based predicate clearance. Standards-verified equivalence. The Abbreviated pathway signals strong alignment with FDA-recognized performance standards - typically associated with lower review burden and faster clearance cycles.

View all Siemens Elema AB devices

Submission Details

510(k) Number K010923 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 27, 2001
Decision Date January 23, 2002
Days to Decision 302 days
Submission Type Abbreviated
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
177d slower than avg
Panel avg: 125d · This submission: 302d
Pathway characteristics
Standards-based clearance path.

Device Classification

Product Code MHX Monitor, Physiological, Patient(with Arrhythmia Detection Or Alarms)
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1025
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - MHX Monitor, Physiological, Patient(with Arrhythmia Detection Or Alarms)

All 161
Devices cleared under the same product code (MHX) and FDA review panel - the closest regulatory comparables to K010923.
SIEMENS INFINITY MODULAR MONITORS, MODELS SC 8000, SC 7000 & SC 9000XL & SIEMENS INFINITY EXPLORER
K022889 · Siemens Medical Solutions USA, Inc. · Sep 2002
DINAMAP PRO 1000 MONITOR, MODEL 1000
K012915 · Ge Medical Systems Information Technologies · Mar 2002
VIEWPOINT CENTRAL MONITORING SYSTEM, MODEL 0998-00-0187-07
K011540 · Datascope Corp. · Feb 2002
SIEMENS INFINITY GATEWAY SUITE
K014213 · Siemens Medical Solutions USA, Inc. · Jan 2002
NIHON KOHDEN BSM-2300A SERIES BEDSIDE MONITOR AND ACCESSORIES, MODEL BSM-2300A SERIES
K011918 · Nihon Kohden America, Inc. · Sep 2001
INFINITY SC 8000 WITH ADVANCED COMMUNICATION OPTION II
K012016 · Siemens Medical Solutions USA, Inc. · Jul 2001